Is Demand for Sterile Injectable Products Driven by Increased Chronic Disease? Chronic disease is on the rise globally with such diseases as cancer, diabetes, and cardiovascular disease; therefore ...
The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...
Pfizer has spent years on the receiving end of the FDA's wrath for continued manufacturing issues surrounding the drugmaker's 2015 buyout of Hospira. Now, after a year of trying to right the ship with ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...
What Endo thought was a real deal has turned into a kill deal. The Dublin-based Endo and its Par sterile injectables subsidiaries Wednesday said a $190 million agreement to buy sterile injectables ...
Dublin, April 30, 2026 (GLOBE NEWSWIRE)-- The "Sterile Injectables CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The sterile injectables CDMO market is witnessing ...
The investment includes the installation of a high-speed, state-of-the-art Groninger UFVN FlexFill syringe, cartridge, and vial filling line and a SKAN isolator to enhance production efficiency and ...
The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...
WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...
BEDFORD, N.H., June 17, 2019 /PRNewswire/ — Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization (CDMO), announced today the acquisition of a ...
WILMINGTON, Del. & WHIPPANY, N.J.--(BUSINESS WIRE)--The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results